Loading...
Structural, NMR Spectroscopic and Computational Investigation of Hemin Loading in the Hemophore HasAp from Pseudomonas aeruginosa
Jepkorir, Grace Juan Carlos, Rodríguez Rui, Huan Im, Wonpil Lovell, Scott Battaile, Kevin P. Alontaga, Aileen Yung Yukl, Erik T. Moënne-Loccoz, Pierre Rivera, Mario
Jepkorir, Grace
Juan Carlos, Rodríguez
Rui, Huan
Im, Wonpil
Lovell, Scott
Battaile, Kevin P.
Alontaga, Aileen Yung
Yukl, Erik T.
Moënne-Loccoz, Pierre
Rivera, Mario
Citations
Altmetric:
Abstract
Heat shock protein 90 (Hsp90) inhibition by modulation of the N-or C-terminal binding site has become an attractive strategy for the development of anti-cancer chemotherapeutics. The first Hsp90 C-terminus inhibitor, novobiocin, manifested a relatively high IC50 value of ~700 μM. Therefore, investigation of the novobiocin scaffold has led to analogs with improved antiproliferative activity (nanomolar concentrations) against several cancer cell lines. During these studies, novobiocin analogs that do not inhibit Hsp90 were identified; however, these analogs demonstrated potent anti-proliferative activity. Compound 2, a novobiocin analog, was identified as a MAPK pathway signaling disruptor that lacked Hsp90 inhibitory activity. In addition, structural modifications of compound 2 were identified that segregated Hsp90 inhibition from MAPK signaling disruption. These studies indicate that compound 2 represents a novel scaffold for disruption of MAPK pathway signaling and may serve as a useful structure for the generation of new anti-cancer agents.
Description
Date
2010-07-21
Journal Title
Journal ISSN
Volume Title
Publisher
American Chemical Society
Collections
Files
Loading...
Jepkorir_2010.pdf
Adobe PDF, 6.17 MB
Research Projects
Organizational Units
Journal Issue
Keywords
Hsp90, Client protein, MAPK signaling pathway, Feed-back mechanism, Structure-activity relationship
Citation
Hall, J. A., Seedarala, S., Zhao, H., Garg, G., Ghosh, S., & Blagg, B. S. J. (2016). Novobiocin Analogs That Inhibit the MAPK Pathway. Journal of Medicinal Chemistry, 59(3), 925–933. http://doi.org/10.1021/acs.jmedchem.5b01354